Related Experiment Videos
Non-insulin dependent diabetes--the past, present and future
1National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-2560, USA.
Annals of the Academy of Medicine, Singapore
|May 1, 1997
Summary
Non-insulin dependent diabetes (NIDDM) involves insulin resistance and impaired insulin secretion. Intensive blood glucose control reduces microvascular complications, while lifestyle changes and new drugs may prevent NIDDM.
Area of Science:
- Endocrinology and Metabolism
- Genetics
- Public Health
Background:
- Diabetes mellitus, historically defined by glycosuria, has evolved from its discovery to understanding its complex mechanisms.
- The identification of insulin and the concept of insulin resistance have been pivotal in diabetes research.
- Non-insulin dependent diabetes (NIDDM) affects over 90% of diabetes cases globally, posing significant health challenges.
Purpose of the Study:
- To review the historical progression of diabetes understanding, focusing on NIDDM.
- To highlight the pathophysiology of NIDDM, including insulin resistance and secretion defects.
- To discuss current and future strategies for NIDDM prevention and management, including lifestyle modifications and pharmacological interventions.
Main Methods:
- Historical review of diabetes research and discovery.
- Analysis of epidemiological data on NIDDM prevalence and risk factors.
- Summary of findings from major clinical trials like the Diabetes Control and Complications Trial (DCCT).
- Overview of genetic research in NIDDM, including candidate gene studies and positional cloning.
Main Results:
- NIDDM is characterized by insulin resistance and subsequent defects in insulin secretion.
- Microvascular complications are linked to hyperglycemia intensity and duration, reducible by intensive glucose control.
- Macrovascular disease, including hypertension and dyslipidemia, is accelerated in NIDDM.
- Major risk factors for NIDDM include age, obesity, inactivity, and genetics.
Conclusions:
- Effective management of NIDDM requires addressing hyperglycemia and cardiovascular risk factors.
- Lifestyle interventions and novel drug classes show promise in delaying or preventing NIDDM.
- Ongoing genetic research aims to identify specific loci and mutations contributing to NIDDM susceptibility.